No significant difference in FUNDC1 mRNA expression was found among varying FIGO stages, tumor grades, or pelvic lymph node metastasis in the EC TCGA cohort (Table S1, all P > 0.05), except for age (χ2 = 5.38, P = 0.02). The gene discussed is FUNDC1; the disease is neoplasm.